ARDT
Ardent Health Partners, LLC NYSE Listed Jul 18, 2024$9.89
Pre-mkt
$9.96
+0.61%
Mkt Cap $1.4B
52w Low $8.07
24.6% of range
52w High $15.48
50d MA $9.31
200d MA $10.71
P/E (TTM)
10.6x
EV/EBITDA
5.8x
P/B
0.8x
Debt/Equity
1.3x
ROE
10.5%
P/FCF
4.8x
RSI (14)
—
ATR (14)
—
Beta
0.57
50d MA
$9.31
200d MA
$10.71
Avg Volume
394.9K
Ardent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, LLC is a subsidiary of EGI-AM Investments, L.L.C.
340 Seven Springs Way · Brentwood, TN 37027 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 0.18 | 0.28 | +55.6% | 10.13 | -1.6% | -7.5% | -2.3% | — | — | — | — |
| Mar 4, 2026 | AMC | 0.35 | 0.32 | -8.0% | 9.64 | -10.6% | -2.1% | -7.7% | -4.9% | -6.2% | -6.4% | — |
| Nov 12, 2025 | AMC | 0.42 | 0.52 | +22.6% | 14.05 | -33.6% | -33.8% | -35.9% | -41.1% | -38.1% | -38.6% | — |
| Aug 5, 2025 | AMC | 0.30 | 0.52 | +73.3% | 10.65 | +10.7% | +6.1% | +7.7% | +11.6% | +13.1% | +17.1% | — |
| May 6, 2025 | AMC | 0.21 | 0.29 | +38.1% | 13.01 | +4.8% | +9.2% | +11.9% | +11.6% | +14.0% | +11.6% | — |
| Feb 26, 2025 | AMC | 0.50 | 0.81 | +62.0% | 14.01 | +11.3% | +8.2% | +4.6% | +7.5% | +7.3% | +9.4% | — |
| Nov 6, 2024 | AMC | 0.30 | 0.17 | -43.3% | 16.27 | -3.7% | +7.8% | +0.6% | +6.4% | +5.3% | +4.5% | — |
| Aug 14, 2024 | AMC | 0.30 | 0.34 | +13.3% | 16.00 | +8.1% | +6.1% | +5.9% | +9.4% | +8.4% | +5.7% | — |
| Mar 31, 2024 | AMC | — | 0.19 | — | — | — | — | — | — | — | — | — |
| Dec 31, 2023 | AMC | — | -0.05 | — | — | — | — | — | — | — | — | — |
| Sep 30, 2023 | AMC | — | 0.15 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2023 | AMC | — | 0.23 | — | — | — | — | — | — | — | — | — |
| Mar 31, 2023 | AMC | — | 0.03 | — | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 | RBC Capital | Maintains | Outperform → Outperform | — | $9.17 | $9.20 | +0.3% | -1.4% | -1.6% | +0.8% | +2.4% | +0.9% |
| Mar 6 | Leerink Partners | Maintains | Outperform → Outperform | — | $9.44 | $9.25 | -2.0% | -5.7% | -2.9% | -4.2% | -4.4% | -2.1% |
| Jan 20 | JP Morgan | Maintains | Neutral → Neutral | — | $8.60 | $8.49 | -1.3% | -3.5% | -0.7% | +0.3% | -0.5% | -1.6% |
| Dec 18 | UBS | Maintains | Buy → Buy | — | $8.94 | $8.93 | -0.1% | -0.1% | -1.5% | -1.3% | -1.5% | +0.3% |
| Dec 18 | Mizuho | Maintains | Outperform → Outperform | — | $8.94 | $8.93 | -0.1% | -0.1% | -1.5% | -1.3% | -1.5% | +0.3% |
| Nov 24 | JP Morgan | Maintains | Neutral → Neutral | — | $8.94 | $8.97 | +0.3% | -0.7% | +2.1% | +1.2% | -1.8% | -1.7% |
| Nov 18 | Guggenheim | Maintains | Buy → Buy | — | $8.28 | $8.56 | +3.4% | +5.1% | +4.2% | +4.3% | +8.0% | +7.2% |
| Nov 18 | Mizuho | Maintains | Outperform → Outperform | — | $8.28 | $8.56 | +3.4% | +5.1% | +4.2% | +4.3% | +8.0% | +7.2% |
| Nov 17 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $9.01 | $8.71 | -3.3% | -8.1% | -3.4% | -4.2% | -4.1% | -0.8% |
| Nov 14 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $9.30 | $9.04 | -2.8% | -3.1% | -11.0% | -6.5% | -7.2% | -7.1% |
| Nov 14 | Truist | Maintains | Buy → Buy | — | $9.30 | $9.04 | -2.8% | -3.1% | -11.0% | -6.5% | -7.2% | -7.1% |
| Nov 14 | Stephens & Co. | Maintains | Overweight → Overweight | — | $9.30 | $9.04 | -2.8% | -3.1% | -11.0% | -6.5% | -7.2% | -7.1% |
| Nov 14 | RBC Capital | Maintains | Outperform → Outperform | — | $9.30 | $9.04 | -2.8% | -3.1% | -11.0% | -6.5% | -7.2% | -7.1% |
| Nov 13 | BofA Securities | Maintains | Underperform → Underperform | — | $14.05 | $9.33 | -33.6% | -33.8% | -35.9% | -41.1% | -38.1% | -38.6% |
| Aug 11 | JP Morgan | Maintains | Neutral → Neutral | — | $11.89 | $11.86 | -0.3% | +1.3% | +4.9% | +6.6% | +5.0% | +5.0% |
| Aug 7 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $11.30 | $10.88 | -3.7% | +1.5% | +5.2% | +6.5% | +10.4% | +12.1% |
| Jul 16 | BofA Securities | Downgrade | Neutral → Underperform | — | $13.92 | $13.25 | -4.8% | -13.7% | -16.8% | -20.2% | -21.3% | -24.5% |
| May 20 | Stephens & Co. | Maintains | Overweight → Overweight | — | $15.15 | $14.98 | -1.1% | -0.1% | -1.4% | -2.3% | -3.5% | -1.8% |
| May 15 | RBC Capital | Maintains | Outperform → Outperform | — | $14.57 | $14.58 | +0.1% | +4.5% | +5.8% | +4.0% | +3.8% | +2.5% |
| May 9 | Guggenheim | Maintains | Buy → Buy | — | $14.56 | $14.72 | +1.1% | -0.3% | +1.9% | -0.3% | +0.1% | +4.6% |
| Apr 9 | Mizuho | Maintains | Outperform → Outperform | — | $11.88 | $11.94 | +0.5% | +6.6% | +1.9% | -0.8% | +4.5% | +3.5% |
| Apr 1 | Stephens & Co. | Maintains | Overweight → Overweight | — | $13.75 | $13.36 | -2.8% | -5.7% | -6.8% | -7.0% | -11.3% | -12.3% |
| Mar 26 | Stephens & Co. | Maintains | Overweight → Overweight | — | $13.11 | $13.16 | +0.4% | +0.0% | +0.4% | +0.7% | +4.9% | -1.1% |
| Mar 4 | RBC Capital | Maintains | Outperform → Outperform | — | $15.06 | $15.09 | +0.2% | -0.2% | +1.7% | -0.6% | -3.2% | -6.6% |
| Feb 27 | Stephens & Co. | Maintains | Overweight → Overweight | — | $14.01 | $15.59 | +11.3% | +8.2% | +4.6% | +7.5% | +7.3% | +9.4% |
| Jan 21 | Morgan Stanley | Maintains | Overweight → Overweight | — | $14.10 | $13.85 | -1.8% | +0.8% | +3.1% | +8.2% | +1.1% | +7.8% |
| Jan 6 | Truist | Maintains | Buy → Buy | — | $16.64 | $16.62 | -0.1% | -4.3% | -1.7% | -1.3% | -5.0% | -3.5% |
| Nov 14 | RBC Capital | Maintains | Outperform → Outperform | — | $17.00 | $17.56 | +3.3% | +4.8% | -2.3% | +0.0% | -2.1% | -3.3% |
| Nov 12 | Leerink Partners | Maintains | Outperform → Outperform | — | $17.31 | $17.34 | +0.2% | -1.0% | -1.8% | +2.9% | -4.0% | -1.8% |
| Nov 6 | BofA Securities | Downgrade | Buy → Neutral | — | $18.05 | $16.47 | -8.8% | -9.9% | -2.8% | -9.3% | -4.1% | -5.0% |
| Sep 19 | Stephens & Co. | Maintains | Overweight → Overweight | — | $17.08 | $17.30 | +1.3% | +5.2% | +7.0% | +11.7% | +13.3% | +13.2% |
| Aug 16 | Loop Capital | Maintains | Buy → Buy | — | $16.97 | $17.01 | +0.2% | -0.2% | +3.1% | +2.2% | -0.4% | +0.3% |
| Aug 16 | Truist | Maintains | Buy → Buy | — | $16.97 | $17.01 | +0.2% | -0.2% | +3.1% | +2.2% | -0.4% | +0.3% |
| Aug 15 | Stephens & Co. | Maintains | Overweight → Overweight | — | $16.00 | $17.29 | +8.1% | +6.1% | +5.9% | +9.4% | +8.4% | +5.7% |
No insider trades available.
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Aravive Biologics' executive departure signals potential leadership uncertainty that could impact pipeline execution and investor confidence in the company's clinical development strategy.
Mar 27
8-K
Ardent Health, Inc. -- 8-K Filing
Ardent Health reported Q4 2025 results, providing investors with updated financial performance and operational metrics for the healthcare provider operating across mid-sized U.S. markets.
Mar 4
Data updated apr 24, 2026 6:47pm
· Source: massive.com